Photobiomodulation in the prevention and the management of side effects of cancer treatments: Bases, results and perspectives

CONCLUSION: Published data suggest that PBM could therefore be considered as supportive care in its own right for patients treated with radiation, chemotherapy, immunotherapy, hormone therapy or targeted therapies, whether in clinical practice or clinical trials. therapies. However, until solid data have been published on its long-term safety, the use of PBM should be considered with caution and within the recommended parameters and doses, particularly when practiced in areas of known or possible tumours. In this case, the patient should be informed of the theoretical benefits and risks of PBM in order to obtain informed consent before treatment.PMID:37858427 | DOI:10.1016/j.bulcan.2023.08.011
Source: Bulletin du Cancer - Category: Cancer & Oncology Authors: Source Type: research